Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 177

1.

Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis.

Palmer SC, Hayen A, Macaskill P, Pellegrini F, Craig JC, Elder GJ, Strippoli GF.

JAMA. 2011 Mar 16;305(11):1119-27. doi: 10.1001/jama.2011.308. Review.

PMID:
21406649
2.

Association of Drug Effects on Serum Parathyroid Hormone, Phosphorus, and Calcium Levels With Mortality in CKD: A Meta-analysis.

Palmer SC, Teixeira-Pinto A, Saglimbene V, Craig JC, Macaskill P, Tonelli M, de Berardis G, Ruospo M, Strippoli GF.

Am J Kidney Dis. 2015 Dec;66(6):962-71. doi: 10.1053/j.ajkd.2015.03.036. Epub 2015 May 21. Review.

3.

Calcium, phosphorus, parathyroid hormone, and cardiovascular disease in hemodialysis patients: the USRDS waves 1, 3, and 4 study.

Slinin Y, Foley RN, Collins AJ.

J Am Soc Nephrol. 2005 Jun;16(6):1788-93. Epub 2005 Apr 6.

4.

Mineral metabolism disorders in chronic kidney disease.

Kestenbaum B.

JAMA. 2011 Mar 16;305(11):1138-9. doi: 10.1001/jama.2011.339. No abstract available.

PMID:
21406655
5.

Calcimimetics for secondary hyperparathyroidism in chronic kidney disease patients.

Ballinger AE, Palmer SC, Nistor I, Craig JC, Strippoli GF.

Cochrane Database Syst Rev. 2014;(12):CD006254. doi: 10.1002/14651858.CD006254.pub2. Epub 2014 Dec 9. Review.

PMID:
25490118
6.

Calcium, phosphorus, PTH and death rates in a large sample of dialysis patients from Latin America. The CORES Study.

Naves-Díaz M, Passlick-Deetjen J, Guinsburg A, Marelli C, Fernández-Martín JL, Rodríguez-Puyol D, Cannata-Andía JB.

Nephrol Dial Transplant. 2011 Jun;26(6):1938-47. doi: 10.1093/ndt/gfq304. Epub 2010 May 31.

PMID:
20513773
7.

[Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].

Lorenzo Sellares V, Torregrosa V.

Nefrologia. 2008;28 Suppl 3:67-78. Spanish.

8.

Vitamin D compounds for people with chronic kidney disease not requiring dialysis.

Palmer SC, McGregor DO, Craig JC, Elder G, Macaskill P, Strippoli GF.

Cochrane Database Syst Rev. 2009 Oct 7;(4):CD008175. doi: 10.1002/14651858.CD008175. Review.

PMID:
19821446
9.

Vitamin D compounds for people with chronic kidney disease requiring dialysis.

Palmer SC, McGregor DO, Craig JC, Elder G, Macaskill P, Strippoli GF.

Cochrane Database Syst Rev. 2009 Oct 7;(4):CD005633. doi: 10.1002/14651858.CD005633.pub2. Review.

PMID:
19821349
10.

Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study.

Block GA, Hulbert-Shearon TE, Levin NW, Port FK.

Am J Kidney Dis. 1998 Apr;31(4):607-17.

PMID:
9531176
11.

Abnormal mineral metabolism and mortality in hemodialysis patients with secondary hyperparathyroidism: evidence from marginal structural models used to adjust for time-dependent confounding.

Fukagawa M, Kido R, Komaba H, Onishi Y, Yamaguchi T, Hasegawa T, Kurita N, Fukuma S, Akizawa T, Fukuhara S.

Am J Kidney Dis. 2014 Jun;63(6):979-87. doi: 10.1053/j.ajkd.2013.08.011. Epub 2013 Oct 8.

PMID:
24119541
12.

Chronic kidney disease: Levels of phosphorus and patient outcomes.

Foley RN.

Nat Rev Nephrol. 2011 Jun 28;7(8):428-30. doi: 10.1038/nrneph.2011.87. No abstract available.

PMID:
21712850
13.

Is there an association between elevated or low serum levels of phosphorus, parathyroid hormone, and calcium and mortality in patients with end stage renal disease? A meta-analysis.

Natoli JL, Boer R, Nathanson BH, Miller RM, Chiroli S, Goodman WG, Belozeroff V.

BMC Nephrol. 2013 Apr 17;14:88. doi: 10.1186/1471-2369-14-88. Review.

14.

Phosphate binders for preventing and treating bone disease in chronic kidney disease patients.

Navaneethan SD, Palmer SC, Vecchio M, Craig JC, Elder GJ, Strippoli GF.

Cochrane Database Syst Rev. 2011 Feb 16;(2):CD006023. doi: 10.1002/14651858.CD006023.pub2. Review.

PMID:
21328279
15.

Association of mineral metabolism factors with all-cause and cardiovascular mortality in hemodialysis patients: the Japan dialysis outcomes and practice patterns study.

Kimata N, Albert JM, Akiba T, Yamazaki S, Kawaguchi T, Fukuhara S, Akizawa T, Saito A, Asano Y, Kurokawa K, Pisoni RL, Port FK.

Hemodial Int. 2007 Jul;11(3):340-8. Erratum in: Hemodial Int. 2009 Jan;13(1):91. Kawaguchi, Yoshindo [corrected to Kawaguchi,Takehiko].

PMID:
17576300
16.

The Kidney Disease Outcomes Quality Initiative (K/DOQI) Guideline for Bone Metabolism and Disease in CKD: association with mortality in dialysis patients.

Noordzij M, Korevaar JC, Boeschoten EW, Dekker FW, Bos WJ, Krediet RT; Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD) Study Group..

Am J Kidney Dis. 2005 Nov;46(5):925-32.

PMID:
16253734
17.

Mineral metabolism, mortality, and morbidity in maintenance hemodialysis.

Block GA, Klassen PS, Lazarus JM, Ofsthun N, Lowrie EG, Chertow GM.

J Am Soc Nephrol. 2004 Aug;15(8):2208-18.

18.

Systematic review of the evidence underlying the association between mineral metabolism disturbances and risk of all-cause mortality, cardiovascular mortality and cardiovascular events in chronic kidney disease.

Covic A, Kothawala P, Bernal M, Robbins S, Chalian A, Goldsmith D.

Nephrol Dial Transplant. 2009 May;24(5):1506-23. doi: 10.1093/ndt/gfn613. Epub 2008 Nov 11. Review.

PMID:
19001560
19.

Plasma parathyroid hormone level and prevalent cardiovascular disease in CKD stages 3 and 4: an analysis from the Kidney Early Evaluation Program (KEEP).

Bhuriya R, Li S, Chen SC, McCullough PA, Bakris GL.

Am J Kidney Dis. 2009 Apr;53(4 Suppl 4):S3-10. doi: 10.1053/j.ajkd.2008.11.029.

PMID:
19285609
20.

Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS).

Tentori F, Blayney MJ, Albert JM, Gillespie BW, Kerr PG, Bommer J, Young EW, Akizawa T, Akiba T, Pisoni RL, Robinson BM, Port FK.

Am J Kidney Dis. 2008 Sep;52(3):519-30. doi: 10.1053/j.ajkd.2008.03.020. Epub 2008 Jun 2.

PMID:
18514987

Supplemental Content

Support Center